XML 94 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investment in Subsidiaries - Additional Information (Detail) (USD $)
12 Months Ended
Sep. 30, 2014
Sep. 30, 2011
Schedule Of Investments [Line Items]    
Ownership percentage in subsidiary 100.00%  
Ablaris Therapeutics
   
Schedule Of Investments [Line Items]    
Ownership percentage in subsidiary 64.00%  
Issuance of preferred stock in subsidiary   $ 2,900,000
Investment in preferred stock   1,300,000
Investment in preferred stock by outsider   1,600,000
Percentage of investment ownership 64.00%  
Calando Pharmaceuticals Inc
   
Schedule Of Investments [Line Items]    
Ownership percentage in subsidiary 79.00%  
Percentage of investment ownership 76.00%  
Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount 87,000  
Amount owed by subsidiary $ 4,500,000  
Stated percentage of notes and advances 8.00%